The role of mitochondria in neurodegenerative diseases: the lesson from Alzheimer's disease and Parkinson's disease

G Monzio Compagnoni, A Di Fonzo, S Corti… - Molecular …, 2020 - Springer
Although the pathogenesis of neurodegenerative diseases is still widely unclear, various
mechanisms have been proposed and several pieces of evidence are supportive for an …

Mitochondria‐targeted nanoparticles in treatment of neurodegenerative diseases

Y Zhang, H Yang, D Wei, X Zhang, J Wang, X Wu… - …, 2021 - Wiley Online Library
Neurodegenerative diseases (NDs) are a class of heterogeneous diseases that includes
Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral …

[HTML][HTML] Mitochondrial dysfunction as a driver of cognitive impairment in Alzheimer's disease

C Sharma, S Kim, Y Nam, UJ Jung, SR Kim - International Journal of …, 2021 - mdpi.com
Alzheimer's disease (AD) is the most frequent cause of age-related neurodegeneration and
cognitive impairment, and there are currently no broadly effective therapies. The underlying …

[HTML][HTML] Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in …

Y Han, C Gao, H Wang, J Sun, M Liang, Y Feng, Q Liu… - Bioactive materials, 2021 - Elsevier
Neuronal mitochondrial dysfunction caused by excessive reactive oxygen species (ROS) is
an early event of sporadic Alzheimer's disease (AD), and considered to be a key pathologic …

PPARγ/PGC1α signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders

S Jamwal, JK Blackburn, JD Elsworth - Pharmacology & Therapeutics, 2021 - Elsevier
Neurodegenerative diseases represent some of the most devastating neurological
disorders, characterized by progressive loss of the structure and function of neurons. Current …

[HTML][HTML] Mitochondria-targeted, nanoparticle-based drug-delivery systems: Therapeutics for mitochondrial disorders

S Buchke, M Sharma, A Bora, M Relekar, P Bhanu… - Life, 2022 - mdpi.com
Apart from ATP generation, mitochondria are involved in a wide range of functions, making
them one of the most prominent organelles of the human cell. Mitochondrial dysfunction is …

[HTML][HTML] Mitochondrial dynamics: a key role in neurodegeneration and a potential target for neurodegenerative disease

D Yang, J Ying, X Wang, T Zhao, S Yoon… - Frontiers in …, 2021 - frontiersin.org
In neurodegenerative diseases, neurodegeneration has been related to several
mitochondrial dynamics imbalances such as excessive fragmentation of mitochondria …

Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice

C Gao, Y Wang, J Sun, Y Han, W Gong, Y Li, Y Feng… - Acta Biomaterialia, 2020 - Elsevier
Biomimetic nanotechnology represents a promising approach for the delivery of therapeutic
agents for the treatment of complex diseases. Recently, neuronal mitochondria have been …

Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems

Y Han, X Chu, L Cui, S Fu, C Gao, Y Li, B Sun - Drug Delivery, 2020 - Taylor & Francis
Reactive oxygen species (ROS)-induced neuronal mitochondrial dysfunction is a key
pathologic factor in sporadic Alzheimer's disease (AD). Neuronal mitochondria have been …

Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target

YN Yang, MQ Zhang, FL Yu, B Han, MY Bao… - Biochemical …, 2023 - Elsevier
Neurodegenerative disorders (NDDs) are characterized by progressive loss of selectively
vulnerable neuronal populations and myelin sheath, leading to behavioral and cognitive …